OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Update on Treatment of Cognitive Impairment Associated with Schizophrenia
William P. Horan, Lauren T. Catalano, Michael F. Green
Current topics in behavioral neurosciences (2022), pp. 407-436
Closed Access | Times Cited: 17
William P. Horan, Lauren T. Catalano, Michael F. Green
Current topics in behavioral neurosciences (2022), pp. 407-436
Closed Access | Times Cited: 17
Showing 17 citing articles:
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials
William P. Horan, Steven D. Targum, Amy Claxton, et al.
Schizophrenia Research (2024) Vol. 274, pp. 57-65
Open Access | Times Cited: 17
William P. Horan, Steven D. Targum, Amy Claxton, et al.
Schizophrenia Research (2024) Vol. 274, pp. 57-65
Open Access | Times Cited: 17
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Treatment Updates in Schizophrenia and Schizophrenia Spectrum Disorders
Nancy Shenoi, Abdulla Alobaidi, Kim-Lan Czelusta, et al.
Psychiatric Annals (2025) Vol. 55, Iss. 1
Closed Access | Times Cited: 1
Nancy Shenoi, Abdulla Alobaidi, Kim-Lan Czelusta, et al.
Psychiatric Annals (2025) Vol. 55, Iss. 1
Closed Access | Times Cited: 1
Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials
W. P. Horan, Amir H Kalali, Stephen K. Brannan, et al.
Schizophrenia Bulletin (2025)
Open Access | Times Cited: 1
W. P. Horan, Amir H Kalali, Stephen K. Brannan, et al.
Schizophrenia Bulletin (2025)
Open Access | Times Cited: 1
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
Samantha E. Yohn, P.D. Harvey, Stephen K. Brannan, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 7
Samantha E. Yohn, P.D. Harvey, Stephen K. Brannan, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 7
Utilizing Technology to Enhance the Ecological Validity of Cognitive and Functional Assessments in Schizophrenia: An Overview of the State-of-the-Art
William P. Horan, Raeanne C. Moore, Heather G. Belanger, et al.
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 5
William P. Horan, Raeanne C. Moore, Heather G. Belanger, et al.
Schizophrenia Bulletin Open (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 5
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials
William P. Horan, Colin Sauder, Philip D. Harvey, et al.
American Journal of Psychiatry (2024)
Closed Access | Times Cited: 4
William P. Horan, Colin Sauder, Philip D. Harvey, et al.
American Journal of Psychiatry (2024)
Closed Access | Times Cited: 4
Capturing changes in social functioning and positive affect using ecological momentary assessment during a 12-month trial of xanomeline and trospium chloride in schizophrenia
Philip D. Harvey, Inder Kaul, Soumya Chataverdi, et al.
Schizophrenia Research (2025) Vol. 276, pp. 117-126
Closed Access
Philip D. Harvey, Inder Kaul, Soumya Chataverdi, et al.
Schizophrenia Research (2025) Vol. 276, pp. 117-126
Closed Access
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives
Irene Calzavara‐Pinton, Gabriele Nibbio, Sergio Barlati, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 791-791
Open Access | Times Cited: 3
Irene Calzavara‐Pinton, Gabriele Nibbio, Sergio Barlati, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 791-791
Open Access | Times Cited: 3
Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways
Ting Zhang, Chang Liu, Ning Zhong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10668-10668
Open Access | Times Cited: 3
Ting Zhang, Chang Liu, Ning Zhong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10668-10668
Open Access | Times Cited: 3
Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways
Ting Zhang, Chang Liu, Ning Zhong, et al.
(2024)
Open Access | Times Cited: 2
Ting Zhang, Chang Liu, Ning Zhong, et al.
(2024)
Open Access | Times Cited: 2
National Institute of Mental Health Support for Cognitive Treatment Development in Schizophrenia: A Narrative Review
Robert Heinssen, Sarah E. Morris, Joel Sherrill
Schizophrenia Bulletin (2024) Vol. 50, Iss. 5, pp. 972-983
Closed Access | Times Cited: 1
Robert Heinssen, Sarah E. Morris, Joel Sherrill
Schizophrenia Bulletin (2024) Vol. 50, Iss. 5, pp. 972-983
Closed Access | Times Cited: 1
The Effects of Cognitive Remediation on Negative Symptoms in Schizophrenia-Spectrum Illness: A Meta-analytic Investigation of Efficacy
Grace Melville, Clara Preisig, Mei C. Zheng, et al.
Schizophrenia Bulletin (2024)
Closed Access | Times Cited: 1
Grace Melville, Clara Preisig, Mei C. Zheng, et al.
Schizophrenia Bulletin (2024)
Closed Access | Times Cited: 1
Cariprazine and cognition in patients with schizophrenia and bipolar disorder: A systematic review
Lorena García‐Fernández, Verónica Romero, Inmaculada Peñuelas‐Calvo, et al.
Research Square (Research Square) (2024)
Open Access
Lorena García‐Fernández, Verónica Romero, Inmaculada Peñuelas‐Calvo, et al.
Research Square (Research Square) (2024)
Open Access
Cognitive impairment and functional outcomes in schizophrenia: a narrative review
Nimali Wanniarachchi, S. M. H. M. K. Senanayake
Sri Lanka Journal of Psychiatry (2024) Vol. 14, Iss. 2, pp. 6-14
Open Access
Nimali Wanniarachchi, S. M. H. M. K. Senanayake
Sri Lanka Journal of Psychiatry (2024) Vol. 14, Iss. 2, pp. 6-14
Open Access
Cognitive Function in Patients with Psychotic and Affective Disorders: Effects of Combining Pharmacotherapy with Cognitive Remediation
E. Maihofer, Gabriele Sachs, Andreas Erfurth
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4843-4843
Open Access
E. Maihofer, Gabriele Sachs, Andreas Erfurth
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4843-4843
Open Access
Ecological validity in cognitive assessment and treatment
Kathryn E. Lewandowski
Schizophrenia Research Cognition (2024) Vol. 40, pp. 100341-100341
Open Access
Kathryn E. Lewandowski
Schizophrenia Research Cognition (2024) Vol. 40, pp. 100341-100341
Open Access
